Pfizer and Morgan State University’s program, a Doctor of Public Health (DrPH) Fellowship in Vaccines Medical Development, will officially begin on August 30th. The collaboration with Morgan State University is part of Pfizer’s continued partnership with Historically Black Colleges and Universities (HBCUs).
The two-year program aims to expand the number of minority scholar practitioners in the fields of medical development, as well as vaccine-related real-world data and analysis. The program will provide fellows the opportunity to:
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.